Dr. Anthony Mazzola, MD

Dr. Mazzola practices at Bislr Medical Groups Of Mount Sinai in New York, New York.

Dr. Mazzola's NPI, 1699139592, was assigned on April 7, 2016. Dr. Mazzola holds New York license 309942.

Dr. Mazzola's primary practice is Bislr Medical Groups of Mount Sinai, at 309 W 23rd St Fl 3 Fl 3, New York, NY 10011. The practice phone is (212) 352-2600.

Dr. Mazzola's primary practice is Bislr Medical Groups Of Mount Sinai in New York, New York. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Mazzola to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mazzola practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Mazzola's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Mazzola is licensed in New York.

CMS data shows 2,818 Medicare services from Dr. Mazzola across 17 procedure codes in 2024, for 240 Medicare patients. Medicare paid $104,727 for them. Every service was in an office.

CMS counts 240 Medicare patients who saw Dr. Mazzola in 2024. The largest group is 65 to 74, with 104 patients. 73% of them have arthritis, and 73% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mazzola's median patient age at 55, with 50% women.

In 2024, Dr. Mazzola wrote 929 Medicare Part D claims for 234 patients. 99% of them were for generic drugs. CMS names the drug for 867 of them, across 10 drugs with 11 or more claims each, at $10,178 in total drug cost. In 2023, CMS named 634 claims across 10 drugs.

Dr. Mazzola accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mazzola as offering telehealth.

Dmand AI links 5 papers to Dr. Mazzola, published from 2019 to 2022. 2019 was the busiest year, with 2. Dr. Mazzola has published most often in J Pain Res. Dr. Mazzola's most frequent co-authors are Douglas P. Beall, MD, Timothy Ray Deer, MD and Dawood Sayed, MD.

CMS Open Payments shows 36 general payments to Dr. Mazzola from 13 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $622.